Objectives: To test the hypothesis that pretreatment with liposomes en
riched with the omega 3 fatty acid docosahexaenoic acid (22:6 omega 3)
will alter the Kupffer's cell and systemic cytokine (tumor necrosis f
actor and interleukin-6) response to endotoxin challenge, and to demon
strate alterations in Kupffer's cell phospholipid fatty acid compositi
on after in vivo liposome treatment. Design: Nonrandomized controlled
laboratory investigation in Wistar rats. Interventions: Animals were a
ssigned to three pretreatment groups: no liposomes; liposomes, 100 mg/
kg; or liposomes, 400 mg/kg given by bolus intravenous injection with
the animals under inhalation anesthesia. Eighteen hours after liposome
treatment, each group was challenged with Escherichia coli lipopolysa
ccharide (3 mg/kg intraperitoneally in 10 mL of lactated Ringer's solu
tion) or lactated Ringer's solution only. In a separate set of experim
ents, Kupffer's cells were obtained from animals pretreated with lipos
ome, 400 mg/kg, or controls and challenged with lipopolysaccharide (1,
100, or 10(4) ng/mL) in vitro. Measures: Serum and Kupffer's cell sup
ernatant tumor necrosis factor and interleukin-6 bioactivity, Kupffer'
s cell phospholipid fatty acid composition, survival, and liver histol
ogic findings. Results: In vivo liposome pretreatment (400 mg/kg) resu
lted in significant increases in serum tumor necrosis factor and inter
leukin-6 levels 90 minutes after intraperitoneal lipopolysaccharide ch
allenge (P < .05 vs no liposomes). Kupffer's cells isolated from lipos
ome-treated animals (400 mg/kg) compared with untreated controls relea
se significantly more tumor necrosis factor and interleukin-6 after li
popolysaccharide stimulation in vitro in a dose-dependent response (P
< .05), Liposome treatment increased total polyunsaturated fatty acid,
total omega 3, and docosahexaenoic acid 22:6 omega 3 content in Kupff
er's cell phospholipids compared with untreated controls. Survival 24
hours after lipopolysaccharide challenge was reduced by liposome (400
mg/kg) pretreatment (P < .05 by chi(2) test). Livers from each treatme
nt group demonstrated focal areas of hepatocyte necrosis and inflammat
ory cells. Conclusion: Liposome pretreatment increases the circulating
and Kupffer's cell cytokine response to endotoxemia, increases Kupffe
r's cell polyunsaturated fatty acid content, and is associated with re
duced survival.